Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants

Pediatric Pulmonology

Volumn 39, Issue 5, 2005, Pages 426-432

  Yanamandra, Krishna ^a   Boggs, Peter ^a   Loggins, John ^a   Baier, R John ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bronchopulmonary dysplasia; Gene polymorphism; Interleukin 10; Prematurity

Indexed keywords

BERACTANT; CYTOKINE; INTERLEUKIN 10; LUNG SURFACTANT;

ACUTE LUNG INJURY; AFRICAN AMERICAN; ALLELE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; BRAIN HEMORRHAGE; CAUCASIAN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; ENCEPHALOMALACIA; ETHNOLOGY; FEMALE; GENDER; GENE LOCATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GESTATIONAL AGE; HETEROZYGOSITY; HISPANIC; HOMOZYGOSITY; HUMAN; INCIDENCE; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOPLASMA HOMINIS; NONHUMAN; OUTCOMES RESEARCH; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UREAPLASMA UREALYTICUM; VERY LOW BIRTH WEIGHT;

ADENINE; ALLELES; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; CAUSE OF DEATH; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; GUANINE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTERLEUKIN-10; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEX FACTORS; TRACHEA;

EID: 17444404935     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20182     Document Type: Article

References (46)

1. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001;160:457-463.
2. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
3. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003;8:73-81.
4. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, Bland RD. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 1999;159:945-958.
5. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-717.
6. Baier RJ, Loggins J, Kruger TE. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Invest Med 2001;49:362-369.
7. Munshi UK, Niu JO, Siddiq MM, Parton LA. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997;24:331-336.
8. Rindfleisch MS, Hasday JD, Taciak V, Broderick K, Viscardi RM. Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res 1996;16:365-373.
9. Jonsson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid: indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;77:198-201.
10. Murch SH, Costeloe K, Klein NJ, MacDonald TT. Early production of macrophage inflammatory protein-α occurs in respiratory distress syndrome and is associated with a poor outcome. Pediatr Res 1996;40:490-497.
11. Nicod LP, el Habre F, Dayer JM, Boehringer N. Interleukin-10 decreases tumor necrosis factor alpha and beta in alloreactions induced by human lung dendritic cells and macrophages. Am J Respir Cell Mol Biol 1995;13:83-90.
12. Thomassen MJ, Divis LT, Fisher CJ. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin Immunol Immunopathol 1996;80:321-324.
13. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995;270:9558-9563.
14. Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997;159:3483-3489.
15. Driscoll KE, Carter JM, Howard BW, Hassenbein D, Burdick M, Kunkel SL, Strieter RM. Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. Am J Physiol 1998;275:887-894.
16. Dokka S, Malanga CJ, Shi X, Chen F, Castranova V, Rojanasakul Y. Inhibition of endtoxin-induced lung inflammation by interleukin-10 gene transfer in mice. Am J Physiol (Lung Cell Mol Physiol) 2000;279:872-877.
17. Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 1998;19:812-818.
18. Kwong KY, Jones CA, Cayabyab R, Lecart C, Khuu N, Rhandhawa I, Hanley JM, Ramanathan R, deLemos RA, Minoo P. The effects of IL-10 on proinflammatory cytokine expression (IL-1beta and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol 1998;88:105-113.
19. McColm JR, Stenson BJ, Biermasz N, McIntosh N. Measurement of interleukin-10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neontal Ed 2000;82:156-159.
20. Huang H-C, Yang M-Y, Huang C-B, Yang KD. Profiles of inflammatory cytokines in bronchoalveolar lavage fluid from premature infants with respiratory distress syndrome. J Microbiol Immunol Infect 2000;33:19-24.
21. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-975.
22. Jonsson B, Li YH, Noack G, Brauner A, Tullus K. Down-regulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr Scand 2000;89:1375-1380.
23. Westendorp RGJ, Langermans JAM, Huizinga TWJ, Elouali AH, Verweij CL, Boomsma DI, Vandenbrouke JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-173.
24. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphisms in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
25. Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel P, Dalhoff K. Pneumococcal septic shock is associated with the interleukin-10 -1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003;168:476-480.
26. Haukim N, Bidwell JL, Smith AJ, Keen LJ, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002;3:313-330.
27. Lech-Maranda E, Baseggio L, Bienvenu J, Chariot C, Berger F, Rigal D, Warzocha K, Coiffier B, Salles G. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004;103:3529-3534.
28. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997;46:120-128.
29. Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995;7:1-7.
30. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transplant Immunol 1998;6:193-197.
31. Baier RJ, Loggins J, Kruger TE. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage. Pediatr Pulmonol 2002;34:131-137.
32. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
33. Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979;95:819-823.
34. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527-532.
35. Kalish RB, Vardhana S, Gupta M, Perni SC, Witkin SS. Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations. Am J Obstet Gynecol 2004;190:702-706.
36. Mormann M, Rieth H, Hua TD, Assohou C, Roupelieva M, Hu SL, Kremsner PG, Luty AJ, Kube D. Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun 2004;5:246-255.
37. De Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Heimerhorst FM, Huizinga TW. Interleukin 10 -2849AA genotype protects against pre-eclampsia. Genes Immun 2004;5:313-314.
38. de Jong BA, Westendorp RG, Eskdale J, Uitdehaag BM, Huizinga TW. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum Immunol 2002;63:281-285.
39. Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun 2003;4:533-540.
40. Treszl A, Kocsis I, Szathmari M, Schuler A, Heninger E, Tulassay T, Vasarhelyi B. Genetic variants of TNF-alpha, IL-1beta, IL-4 receptor alpha-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003;83:241-245.
41. Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun 2000;1:321-324.
42. Timmann C, Fuchs S, Thoma C, Lepping B, Brattig NW, Sievertsen J, Thye T, Muller-Myhsok B, Horstmann RD. Promoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen. Genes Immun 2004;5:256-260.
43. Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha -308, MCP-1 -2518 and TGF-beta(1) +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 2003;4:420-426.
44. Manar MH, Brown MR, Gauthier TW, Brown LA. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatal 2004;24:30-35.
45. Weber B, Borkhardt A, Stoll-Becker S, Reiss I, Gortner L. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Turk J Pediatr 2000;42:181-185.
46. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004;13:1095-1104.